Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Glioblastoma 41Glioma 18Brain Neoplasms 14Astrocytoma 11Neuroblastoma 10Gliosarcoma 10Neoplasms 8Sarcoma, Ewing 7Rhabdomyosarcoma 6Recurrence 5Oligodendroglioma 5Sarcoma 4Medulloblastoma 4Neoplasm Metastasis 3Diffuse Intrinsic Pontine Glioma 3Wilms Tumor 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Osteosarcoma 2Melanoma 2Lymphoma, Follicular 2Hepatoblastoma 2Central Nervous System Neoplasms 2Spinal Cord Neoplasms 1Somatostatinoma 1Rhabdoid Tumor 1Refractory Solid Tumors 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pheochromocytoma 1

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2LY3023414 2talazoparib 1olaparib 1irinotecan sucrosofate 1amino-acid, glucose, and electrolyte solution 1Vemurafenib 1Temozolomide 1Pharmacogenomic Variants 1Liquid Biopsy 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors, Primitive, Peripheral × Temozolomide × 90 days × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡